Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Shares Outstanding (Weighted Average): 2021-2025

Historic Shares Outstanding (Weighted Average) for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to $10.7 million.

  • Biofrontera's Shares Outstanding (Weighted Average) rose 92.45% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 92.45%. This contributed to the annual value of $7.7 million for FY2024, which is 410.61% up from last year.
  • Biofrontera's Shares Outstanding (Weighted Average) amounted to $10.7 million in Q3 2025, which was up 12.94% from $9.4 million recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Shares Outstanding (Weighted Average) peaked at $10.7 million during Q3 2025, and registered a low of $550,000 during Q2 2021.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $5.1 million (2024), whereas its average is $5.3 million.
  • Data for Biofrontera's Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 410.61% (in 2024) over the last 5 years.
  • Over the past 5 years, Biofrontera's Shares Outstanding (Weighted Average) (Quarterly) stood at $752,800 in 2021, then soared by 77.33% to $1.3 million in 2022, then grew by 13.68% to $1.5 million in 2023, then skyrocketed by 410.61% to $7.7 million in 2024, then skyrocketed by 92.45% to $10.7 million in 2025.
  • Its last three reported values are $10.7 million in Q3 2025, $9.4 million for Q2 2025, and $8.9 million during Q1 2025.